Search research articles
Contact Us
Filters
Showing results (1-10 of 257) with videos related to
Page
of 26
Sort By:
Thorax
|
July 19, 2017
Divide and conquer: identifying acute respiratory distress syndrome subphenotypes
Manu Shankar-Hari, Daniel F McAuley
American Journal of Respiratory and Critical Care Medicine
|
September 3, 2011
Pro: β-agonists in acute lung injury--the end of the story?
Gavin D Perkins, Daniel F McAuley
Critical Care Medicine
|
July 19, 2013
Out with the old or better use of the old? A quest in sedation*
Valerie J Page, Daniel F McAuley
Lancet (London, England)
|
April 20, 2017
Prolonged glucocorticoid treatment in acute respiratory distress syndrome - Authors' reply
Rob Mac Sweeney, Daniel F McAuley
Lancet (London, England)
|
May 3, 2016
Acute respiratory distress syndrome
Rob Mac Sweeney, Daniel F McAuley
American Journal of Respiratory and Critical Care Medicine
|
February 2, 2017
Acute Respiratory Distress Syndrome Phenotypes and Identifying Treatable Traits. The Dawn of Personalized Medicine for ARDS
Manu Shankar-Hari, Daniel F McAuley
Clinics in Chest Medicine
|
December 3, 2014
Clinical trial design in prevention and treatment of acute respiratory distress syndrome
Gerard F Curley, Daniel F McAuley
Current Opinion in Anaesthesiology
|
January 31, 2015
Sedation/drugs used in intensive care sedation
Valerie J Page, Daniel F McAuley
Critical Care Medicine
|
December 1, 2020
Will Not Breathing on Extracorporeal Membrane Oxygenation Help One Survive Acute Respiratory Distress Syndrome?
Kiran Shekar, Daniel F McAuley, Daniel Brodie
Expert Opinion on Emerging Drugs
|
August 26, 2014
Is there a need for emerging drugs for the acute respiratory distress syndrome?
Marianne Fitzgerald, Daniel F McAuley, Michael Matthay
Page
of 26
Search research articles
Search
Showing results (1-10 of 257) with videos related to
Sort By:
Page
of 26
Thorax
|
July 19, 2017
Divide and conquer: identifying acute respiratory distress syndrome subphenotypes
Manu Shankar-Hari, Daniel F McAuley
American Journal of Respiratory and Critical Care Medicine
|
September 3, 2011
Pro: β-agonists in acute lung injury--the end of the story?
Gavin D Perkins, Daniel F McAuley
Critical Care Medicine
|
July 19, 2013
Out with the old or better use of the old? A quest in sedation*
Valerie J Page, Daniel F McAuley
Lancet (London, England)
|
April 20, 2017
Prolonged glucocorticoid treatment in acute respiratory distress syndrome - Authors' reply
Rob Mac Sweeney, Daniel F McAuley
Lancet (London, England)
|
May 3, 2016
Acute respiratory distress syndrome
Rob Mac Sweeney, Daniel F McAuley
American Journal of Respiratory and Critical Care Medicine
|
February 2, 2017
Acute Respiratory Distress Syndrome Phenotypes and Identifying Treatable Traits. The Dawn of Personalized Medicine for ARDS
Manu Shankar-Hari, Daniel F McAuley
Clinics in Chest Medicine
|
December 3, 2014
Clinical trial design in prevention and treatment of acute respiratory distress syndrome
Gerard F Curley, Daniel F McAuley
Current Opinion in Anaesthesiology
|
January 31, 2015
Sedation/drugs used in intensive care sedation
Valerie J Page, Daniel F McAuley
Critical Care Medicine
|
December 1, 2020
Will Not Breathing on Extracorporeal Membrane Oxygenation Help One Survive Acute Respiratory Distress Syndrome?
Kiran Shekar, Daniel F McAuley, Daniel Brodie
Expert Opinion on Emerging Drugs
|
August 26, 2014
Is there a need for emerging drugs for the acute respiratory distress syndrome?
Marianne Fitzgerald, Daniel F McAuley, Michael Matthay
Page
of 26